Intelligent Photonics

Invuity’s patented Intelligent Photonics® devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.

Find out more about our technology

waveguide-home

Transforming Minimal access Surgeries Through Advanced Visualization

Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.

precision-efficiency-safety

Invuity Announces 2018 Second Quarter Financial Results and Conference Call Date

SAN FRANCISCO, July 20, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 second quarter financial results after the market closes on Thursday, August 2, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on Thursday, August 2, 2018, to discuss the financial results and other business developments. Interested parties may access the live call via telephone by dialing 1-877-556-8638 (U.S.) or 1-615-247-0174 (International), Conference ID: 2364838. To listen to th...

Read More

Invuity to Present at William Blair Annual Growth Stock Conference

SAN FRANCISCO, May 29, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at the 38th Annual Growth Stock Conference on Tuesday, June 12, 2018 at 9:30 a.m. Central Time in Chicago. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation. About Invu...

Read More

Invuity Announces Results of New PhotonBlade® Studies at 2018 Heart Rhythm Society Conference

Researchers identify critical factors to minimize damage when using electrocautery near insulated pacing leads and demonstrate a reduced risk of damaging lead insulation with the use of PhotonBlade SAN FRANCISCO, May 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the results of two studies that were published at the Scientific Sessions of the Heart Rhythm Society in Boston last week.  The studies were co-authored by teams from Northwestern University and University of Pennsylvania and focused on the potential risk of damage to the insulation of pacing leads related to the use of electrocaute...

Read More

Testimonials

“The light improves my visualization in the surgical field, allowing me to be more precise with my bone cuts and joint preparation”

Selene Parekh, MD
North Carolina Orthopaedic Clinic
Durham, NC

“This is revolutionary technology that will change the way we do minimally invasive breast surgery. It is simply must have instrumentation to work more confident, and efficient in delicate anatomy.”

Lorraine Tafra, MD
Director of Breast Center
Anne Arundel Medical Center
Annapolis, MD

“These retractors are a must for anyone looking to do nipple sparing mastectomies. I feel we can save significant amounts of surgical time since we can see better without the worry of burn injury or fire hazard often found with fiber optic light.”

Rache Simmons, MD
New York Presbyterian/Weill Cornell Medical Center
New York, NY